HRP20100027T1 - Upotreba kompleksnih spojeva željeza (iii) - Google Patents
Upotreba kompleksnih spojeva željeza (iii) Download PDFInfo
- Publication number
- HRP20100027T1 HRP20100027T1 HR20100027T HRP20100027T HRP20100027T1 HR P20100027 T1 HRP20100027 T1 HR P20100027T1 HR 20100027 T HR20100027 T HR 20100027T HR P20100027 T HRP20100027 T HR P20100027T HR P20100027 T1 HRP20100027 T1 HR P20100027T1
- Authority
- HR
- Croatia
- Prior art keywords
- iron
- iii
- use according
- medicine
- maltodextrins
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 9
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 title claims abstract 7
- 239000003814 drug Substances 0.000 claims abstract 6
- 210000004556 brain Anatomy 0.000 claims abstract 2
- 230000007124 immune defense Effects 0.000 claims abstract 2
- 229920002774 Maltodextrin Polymers 0.000 claims 7
- 229920002245 Dextrose equivalent Polymers 0.000 claims 3
- 239000007864 aqueous solution Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 230000003647 oxidation Effects 0.000 claims 3
- 238000007254 oxidation reaction Methods 0.000 claims 3
- 206010022971 Iron Deficiencies Diseases 0.000 claims 2
- 239000005913 Maltodextrin Substances 0.000 claims 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims 2
- 210000004698 lymphocyte Anatomy 0.000 claims 2
- 229940035034 maltodextrin Drugs 0.000 claims 2
- 108010047620 Phytohemagglutinins Proteins 0.000 claims 1
- 208000007502 anemia Diseases 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 210000000440 neutrophil Anatomy 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 230000001885 phytohemagglutinin Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05100907 | 2005-02-09 | ||
| PCT/EP2006/050276 WO2006084782A1 (de) | 2005-02-09 | 2006-01-18 | Verwendung von eisen(iii)-komplexverbindungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20100027T1 true HRP20100027T1 (hr) | 2010-02-28 |
Family
ID=34938674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100027T HRP20100027T1 (hr) | 2005-02-09 | 2010-01-14 | Upotreba kompleksnih spojeva željeza (iii) |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US8722101B2 (ja) |
| EP (1) | EP1848446B1 (ja) |
| JP (1) | JP5060312B2 (ja) |
| KR (1) | KR20070107106A (ja) |
| CN (1) | CN101155593A (ja) |
| AT (1) | ATE445406T1 (ja) |
| AU (1) | AU2006212322B2 (ja) |
| BR (1) | BRPI0606974A2 (ja) |
| CA (1) | CA2597154C (ja) |
| CR (1) | CR9300A (ja) |
| CY (1) | CY1109685T1 (ja) |
| DE (1) | DE502006005100D1 (ja) |
| DK (1) | DK1848446T3 (ja) |
| ES (1) | ES2333814T3 (ja) |
| HR (1) | HRP20100027T1 (ja) |
| IL (1) | IL185020A (ja) |
| MX (1) | MX2007009588A (ja) |
| NO (1) | NO20074536L (ja) |
| PL (1) | PL1848446T3 (ja) |
| PT (1) | PT1848446E (ja) |
| RU (1) | RU2359680C2 (ja) |
| SI (1) | SI1848446T1 (ja) |
| TN (1) | TNSN07307A1 (ja) |
| UA (1) | UA88347C2 (ja) |
| WO (1) | WO2006084782A1 (ja) |
| ZA (1) | ZA200707716B (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10249552A1 (de) | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
| EP3081219A1 (en) | 2006-01-06 | 2016-10-19 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron |
| EP2165713B1 (en) * | 2008-09-19 | 2012-11-14 | Nestec S.A. | Whey and thymus function |
| NZ595597A (en) * | 2009-03-25 | 2013-05-31 | Pharmacosmos Holding As | A stable iron oligosaccharide compound |
| WO2012104204A1 (en) | 2011-01-31 | 2012-08-09 | Vifor (International) Ag | Iron-carbohydrate complex compounds for the intravenous therapy of malaria |
| US11395502B2 (en) * | 2012-10-18 | 2022-07-26 | Patrick Monsivais | Formulation for iron supplements |
| AU2014242974A1 (en) * | 2013-03-28 | 2015-07-09 | Vifor (International) Ag | Fe(lll) complexes for treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias |
| KR20150078375A (ko) * | 2013-12-30 | 2015-07-08 | 한화케미칼 주식회사 | 철산화물 나노입자를 포함하는 철결핍증의 예방 또는 치료용 약학 조성물 |
| FR3075001B1 (fr) * | 2017-12-14 | 2021-09-10 | Tereos Starch & Sweeteners Belgium | Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau |
| CN114288320A (zh) * | 2021-12-29 | 2022-04-08 | 珠海天翼医药技术开发有限公司 | 一种猪用口服补铁剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3076798A (en) * | 1961-02-23 | 1963-02-05 | Hausmann Lab Ltd | Process for preparing a ferric hydroxide polymaltose complex |
| US3766165A (en) * | 1966-08-17 | 1973-10-16 | Pfizer | Polysaccharides and their preparation |
| DE4421159C1 (de) * | 1994-06-20 | 1995-08-24 | Thomas Bruns | Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche |
| DE19734293A1 (de) * | 1997-08-08 | 1999-02-11 | Boehringer Mannheim Gmbh | Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen |
| AU2002220280A1 (en) * | 2000-12-07 | 2002-06-18 | Ad "Zdravlje" Farmaceutsko - Hemijska Industrija, Centar Za Istrazivanje I Razvoj | Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex |
| US6821547B2 (en) * | 2001-04-10 | 2004-11-23 | Danisco Usa, Inc. | Polymerization of mono and disaccharides with monocarboxylic acids and lactones |
| AU2003226923B2 (en) | 2002-04-09 | 2006-08-17 | Pharmacosmos Holding A/S | iron dextrin compounds for the treatment of iron deficiency anaemia |
| DE10249552A1 (de) * | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
-
2006
- 2006-01-18 AU AU2006212322A patent/AU2006212322B2/en not_active Ceased
- 2006-01-18 MX MX2007009588A patent/MX2007009588A/es active IP Right Grant
- 2006-01-18 WO PCT/EP2006/050276 patent/WO2006084782A1/de active Application Filing
- 2006-01-18 EP EP06707742A patent/EP1848446B1/de active Active
- 2006-01-18 PL PL06707742T patent/PL1848446T3/pl unknown
- 2006-01-18 CN CNA2006800115263A patent/CN101155593A/zh active Pending
- 2006-01-18 DK DK06707742.0T patent/DK1848446T3/da active
- 2006-01-18 PT PT06707742T patent/PT1848446E/pt unknown
- 2006-01-18 RU RU2007133509/15A patent/RU2359680C2/ru not_active IP Right Cessation
- 2006-01-18 JP JP2007554530A patent/JP5060312B2/ja not_active Expired - Fee Related
- 2006-01-18 DE DE502006005100T patent/DE502006005100D1/de active Active
- 2006-01-18 CA CA2597154A patent/CA2597154C/en not_active Expired - Fee Related
- 2006-01-18 BR BRPI0606974-6A patent/BRPI0606974A2/pt not_active IP Right Cessation
- 2006-01-18 AT AT06707742T patent/ATE445406T1/de active
- 2006-01-18 KR KR1020077020249A patent/KR20070107106A/ko not_active Application Discontinuation
- 2006-01-18 SI SI200630432T patent/SI1848446T1/sl unknown
- 2006-01-18 US US11/815,568 patent/US8722101B2/en not_active Expired - Fee Related
- 2006-01-18 UA UAA200708978A patent/UA88347C2/ru unknown
- 2006-01-18 ES ES06707742T patent/ES2333814T3/es active Active
-
2007
- 2007-08-02 IL IL185020A patent/IL185020A/en not_active IP Right Cessation
- 2007-08-08 TN TNP2007000307A patent/TNSN07307A1/en unknown
- 2007-08-09 CR CR9300A patent/CR9300A/es unknown
- 2007-09-07 NO NO20074536A patent/NO20074536L/no not_active Application Discontinuation
- 2007-09-07 ZA ZA200707716A patent/ZA200707716B/xx unknown
-
2009
- 2009-12-14 CY CY20091101333T patent/CY1109685T1/el unknown
-
2010
- 2010-01-14 HR HR20100027T patent/HRP20100027T1/hr unknown
-
2014
- 2014-03-10 US US14/202,056 patent/US20140187514A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200707716B (en) | 2008-06-25 |
| AU2006212322A1 (en) | 2006-08-17 |
| NO20074536L (no) | 2007-11-05 |
| US20080214496A1 (en) | 2008-09-04 |
| CA2597154C (en) | 2011-03-15 |
| MX2007009588A (es) | 2007-09-12 |
| US20140187514A1 (en) | 2014-07-03 |
| RU2359680C2 (ru) | 2009-06-27 |
| PT1848446E (pt) | 2009-12-21 |
| SI1848446T1 (sl) | 2010-01-29 |
| RU2007133509A (ru) | 2009-03-20 |
| UA88347C2 (ru) | 2009-10-12 |
| ATE445406T1 (de) | 2009-10-15 |
| CY1109685T1 (el) | 2014-08-13 |
| CA2597154A1 (en) | 2006-08-17 |
| BRPI0606974A2 (pt) | 2009-07-28 |
| JP2008530049A (ja) | 2008-08-07 |
| IL185020A (en) | 2013-10-31 |
| ES2333814T3 (es) | 2010-03-01 |
| CR9300A (es) | 2007-12-07 |
| IL185020A0 (en) | 2007-12-03 |
| PL1848446T3 (pl) | 2010-03-31 |
| TNSN07307A1 (en) | 2008-12-31 |
| EP1848446A1 (de) | 2007-10-31 |
| DE502006005100D1 (de) | 2009-11-26 |
| CN101155593A (zh) | 2008-04-02 |
| JP5060312B2 (ja) | 2012-10-31 |
| WO2006084782A1 (de) | 2006-08-17 |
| EP1848446B1 (de) | 2009-10-14 |
| KR20070107106A (ko) | 2007-11-06 |
| DK1848446T3 (da) | 2010-02-15 |
| US8722101B2 (en) | 2014-05-13 |
| AU2006212322B2 (en) | 2012-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20100027T1 (hr) | Upotreba kompleksnih spojeva željeza (iii) | |
| Blinkova et al. | Biological activity of Spirulina Zh Mikrobiol Epidemiol Immunobiol. 2001 Mar-Apr;(2): 114–8. Review. In this review information of Spirulina platensis (SP), a blue-green alga (photosynthesizing cyanobacterium) having diverse biological activity is presented. Due to high content of highly | |
| RU2008111148A (ru) | Применение комплексных соединений железа (iii) для производства лекарственного средства для перорального лечения железодефицитных состояний у больных, страдающих хроническими воспалительными заболеваниями кишечника | |
| RU2008125327A (ru) | Препарат, содержащий комплексные соединения железа (iii) и активное окислительно-восстановительное вещество | |
| BR0315452A (pt) | Complexos aquosos de carboidrato de ferro, sua produção e medicamentos contendo os mesmos | |
| RU2009110912A (ru) | Средство и продукт питания для профилактики/уменьшения проявлений функционального расстройства пищеварения | |
| RU2002106399A (ru) | Составы моксифлоксацина, содержащие поваренную соль | |
| BRPI0513455A (pt) | formulação para mascaramento de sabor compreendendo o fármaco em uma forma de dissolução retardada e/ou ciclodextrina em uma forma de dissolução melhorada | |
| MY144565A (en) | Use of glutamate or of glutamic acid for the prevention of hyperpermeability or undesired permeability of the intestinal wall | |
| CN101693037A (zh) | 黄酮苷类化合物在制备治疗疟疾的药物中应用 | |
| HRP20220691T1 (hr) | Poboljšanja u i u vezi s pripravcima | |
| EA200501621A1 (ru) | Антигриппозное средство | |
| RU2217138C1 (ru) | Состав "витализин-2" для профилактики атеросклероза, сердечно-сосудистых заболеваний и поддерживающей терапии вирусных заболеваний | |
| KR102062136B1 (ko) | 옥미수·호박 가미 경옥고를 유효성분으로 함유하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품 | |
| RU2020114190A (ru) | Композиция для кратковременного и долговременного лечения запоров | |
| ATE281832T1 (de) | Pharmazeutische zusammensetzungen mit antitumoraler wirkung auf basis von carboplatin | |
| CN101693028A (zh) | 紫草酸酯类化合物在制备治疗疟疾药物中的应用 | |
| CN102775519B (zh) | 一种壳聚糖谷氨酸盐增鲜剂 | |
| CN102775521B (zh) | 一种壳聚糖鸟苷酸盐增味剂 | |
| RU2217141C1 (ru) | Состав "витализин-1" для профилактики атеросклероза, сердечно-сосудистых заболеваний и поддерживающей терапии вирусных заболеваний | |
| DE602004003225D1 (de) | Kaliumtauratbikarbonat und ascorbat komplexe | |
| JPS584724A (ja) | 免疫賦活剤 | |
| TH2003002835C3 (th) | วิตามินผสม | |
| CN102816348A (zh) | 一种壳聚糖天冬氨酸琥珀酸复合盐及其作为增鲜剂的应用 | |
| JP2013053135A (ja) | 内服製剤 |